Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR013818)
Formula
SVG example
Unclear
Reactant Oxycodone Product Noroxycodone
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 3A4 (CYP3A4) DME Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR013822 Oxycodone (Alpha and beta)-Oxycodol Unclear - Unclear Oxycodone [1]
MR013823 Oxycodone Oxycodone N-oxide Unclear - Unclear Oxycodone [1]
MR013820 Oxycodone Oxymorphone Unclear - Unclear Oxycodone [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001881 Oxycodone hydrochloride Noroxycodone Oxidation - N-Demethylation Oxycodone hydrochloride [2], [3], [4]
MR001899 Oxymorphone Noroxycodone Oxidation - N-Demethylation Oxymorphone [5]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001880 Noroxycodone Beta-Noroxycodol Reduction - 6-Ketoreduction Oxycodone hydrochloride [6]
MR001879 Noroxycodone Nor-6alpha-Oxycodol Reduction - 6-Ketoreduction Oxycodone hydrochloride [6]
MR001878 Noroxycodone Noroxymorphone Oxidation - N-Demethylation Oxycodone hydrochloride [2], [3]
MR013819 Noroxycodone Noroxymorphone Unclear - Unclear Oxycodone [1]
References
1 Metabolism and Disposition of Prescription Opioids: A Review
2 Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004 Apr;32(4):447-54.
3 Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer. Clin Pharmacokinet. 2023 May 10. doi: 10.1007/s40262-023-01255-1.
4 Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests. Pharmacogenomics J. 2022 Feb;22(1):25-32. doi: 10.1038/s41397-021-00253-5.
5 Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. Br J Clin Pharmacol. 2010 Jul;70(1):78-87.
6 DrugBank(Pharmacology-Metabolism)Oxycodone hydrochloride

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.